[Predictive and prognostic significance of PCNA, p53, bcl-2 and intratumor vessel density in radiochemotherapy of advanced head and neck tumors].
Grabenbauer
G G
GG
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000098:blood supply / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D019254:Genes, bcl-2; D016158:Genes, p53; D006258:Head and Neck Neoplasms / Q000098:blood supply / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D006801:Humans; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen; D011879:Radiotherapy Dosage; D013997:Time Factors
D000970:Antineoplastic Agents; D018809:Proliferating Cell Nuclear Antigen; D016190:Carboplatin; D002945:Cisplatin